APF
NVO

Alaska Permanent Fund’s Novo Nordisk NVO Stock Holding History

Alaska Permanent Fund’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-2,493
Closed -$166K – 301
2025
Q1 		$166K Hold
2,493
– – ﹤0.01% 431
2024
Q4 		$214K Hold
2,493
– – ﹤0.01% 423
2024
Q3 		$297K Hold
2,493
– – ﹤0.01% 412
2024
Q2 		$331K Sell
2,493
-595
-19% -$78.8K ﹤0.01% 407
2024
Q1 		$396K Buy
+3,088
New +$368K 0.01% 423

Other funds holding NVO

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Alaska Permanent Fund's NVO Position: Q2 2025 in Review

Alaska Permanent Fund sold out of Novo Nordisk (NVO) in Q2 2025, closing a stake of 2,493 shares — an estimated $166K sold.

Alaska Permanent Fund first reported a position in NVO in Q1 2024 and held it in 5 quarters. The position peaked at $396K in Q1 2024. 1,481 funds tracked by Wall St. Rank hold NVO as of Q2 2025.

  • Alaska Permanent Fund reported no remaining Novo Nordisk position as of Q2 2025 after selling out during the quarter.
  • Alaska Permanent Fund sold 2,493 Novo Nordisk shares in Q2 2025, an estimated $166K.
  • Alaska Permanent Fund first reported a position in Novo Nordisk in Q1 2024 and held it in 5 quarters.
  • Alaska Permanent Fund's Novo Nordisk position peaked at $396K in Q1 2024.
  • 1,481 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2025.

Based on Alaska Permanent Fund's 13F filing for Q2 2025, filed 14 Aug 2025.